
Hongcheng Zhu/X
Jul 27, 2025, 19:47
Hongcheng Zhu: Anti-Cancer Drug Innovation and Research Development Meeting 2025
Hongcheng Zhu, Radiation and Clinical Oncologist at Fudan University Shanghai Cancer Center, shared a post on X:
“Great to attend Anti-Cancer Drug Innovation and Research Development meeting 2025 and Speciality Committee meeting of PhIRDA. Innovation, industrialization and internationalization through academia-industry-investment collaboration exerts for anti-cancer therapies in China and beyond.”
More posts featuring Hongcheng Zhu.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jul 28, 2025, 03:49
Jul 27, 2025, 19:47
Jul 27, 2025, 17:59